Amedisys Reports Second Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Amedisys (AMED) Tops Q2 EPS by 12c
July 26, 2017 5:02 PM EDTAmedisys (NASDAQ: AMED) reported Q2 EPS of $0.62, $0.12 better than the analyst estimate of $0.50. Revenue for the quarter came in at $378.8 million versus the consensus estimate of $380.7 million.
For earnings history and earnings-related data on Amedisys (AMED) click here.
... More


